CACI (CACI INTERNATIONAL CLA)
Insider Trading Activity
Every open-market purchase and sale reported by CACI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | LISA S DISBROW | Director | A | — | — |
| 2026-07-15 | Ryan D McCarthy | Director | M | — | — |
| 2026-07-15 | LISA S DISBROW | Director | M | — | — |
| 2026-07-15 | Philip O Nolan | Director | M | — | — |
| 2026-07-15 | Susan M. Gordon | Director | M | — | — |
| 2026-07-15 | Stanton D Sloane | Director | M | — | — |
| 2026-07-15 | Debora A Plunkett | Director | M | — | — |
| 2026-07-15 | CHARLES L SZEWS | Director | M | — | — |
| 2026-07-15 | SCOTT C MORRISON | Director | M | — | — |
| 2026-06-25 | David Anthony Young | EVP, Chief Operating Officer | A | — | — |
| 2026-06-18 | Susan M. Gordon | Director | Sell | — | — |
| 2026-04-27 | DeEtte Gray | President, US Operations | MIXED | — | — |
| 2026-04-21 | LISA S DISBROW | Director | A | — | — |
| 2026-04-16 | Stanton D Sloane | Director | M | — | — |
| 2026-04-16 | CHARLES L SZEWS | Director | M | — | — |
| 2026-04-16 | Debora A Plunkett | Director | M | — | — |
| 2026-04-16 | LISA S DISBROW | Director | M | — | — |
| 2026-04-16 | Philip O Nolan | Director | M | — | — |
| 2026-04-16 | SCOTT C MORRISON | Director | M | — | — |
| 2026-04-16 | Ryan D McCarthy | Director | M | — | — |
| 2026-04-16 | Susan M. Gordon | Director | M | — | — |
| 2026-03-12 | Debora A Plunkett | Director | Sell | — | — |
| 2026-02-12 | J William JR Koegel | EVP, General Counsel | Sell | — | — |
| 2026-01-16 | Ryan D McCarthy | Director | M | — | — |
| 2026-01-16 | Debora A Plunkett | Director | M | — | — |
| 2026-01-16 | LISA S DISBROW | Director | MIXED | — | — |
| 2026-01-16 | Stanton D Sloane | Director | M | — | — |
| 2026-01-16 | Susan M. Gordon | Director | M | — | — |
| 2026-01-16 | SCOTT C MORRISON | Director | M | — | — |
| 2026-01-16 | CHARLES L SZEWS | Director | M | — | — |
| 2026-01-16 | Philip O Nolan | Director | M | — | — |
| 2025-12-12 | WILLIAM L JEWS | Director | Sell | — | — |
| 2025-11-04 | JEFFREY D MACLAUCHLAN | Chief Financial Officer | MIXED | — | — |
| 2025-10-20 | Ryan D McCarthy | Director | A | — | — |
| 2025-10-20 | CHARLES L SZEWS | Director | A | — | — |
| 2025-10-20 | Stanton D Sloane | Director | A | — | — |
| 2025-10-20 | LISA S DISBROW | Director | A | — | — |
| 2025-10-20 | Philip O Nolan | Director | A | — | — |
| 2025-10-20 | Susan M. Gordon | Director | A | — | — |
| 2025-10-20 | Debora A Plunkett | Director | A | — | — |
| 2025-10-20 | WILLIAM L JEWS | Director | A | — | — |
| 2025-10-20 | Eric Blazer | SVP, Corp. Controller & CAO | MIXED | — | — |
| 2025-10-20 | SCOTT C MORRISON | Director | A | — | — |
| 2025-10-14 | Susan M. Gordon | Director | M | — | — |
| 2025-10-14 | LISA S DISBROW | Director | M | — | — |
| 2025-10-14 | CHARLES L SZEWS | Director | M | — | — |
| 2025-10-14 | WILLIAM L JEWS | Director | M | — | — |
| 2025-10-14 | SCOTT C MORRISON | Director | M | — | — |
| 2025-10-14 | Ryan D McCarthy | Director | M | — | — |
| 2025-10-14 | Debora A Plunkett | Director | M | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President & CEO | 128,827 | — |
| — | Director | 83,121 | — |
| — | President and CEO | 46,450 | — |
| — | Chief Executive, CACI Limited | 44,971 | — |
| — | President, US Operations | 39,485 | — |
| — | Exec VP & CFO | 35,344 | — |
| — | Director | 34,310 | — |
| — | EVP, General Counsel | 25,931 | — |
| — | Director | 13,818 | — |
| — | Director | 12,268 | — |
| — | Chief Financial Officer | 7,475 | — |
| — | Director | 7,056 | — |
| — | President, OSS | 6,840 | — |
| — | Director | 6,042 | — |
| — | President, Nat Sec & Innov Sol | 5,426 | — |
| — | Director | 5,346 | — |
| — | SrVP, Corp. Controller | 5,008 | — |
| — | Chief Executive Officer, UK | 3,747 | — |
| — | Director | 3,384 | — |
| — | President, NSIS | 3,365 | — |
| — | Director | 3,255 | — |
| — | Director | 2,726 | — |
| — | Director | 2,597 | — |
| — | Director | 2,510 | — |
| — | Director | 2,322 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CACI quote page; the site-wide leaderboard is on the insider transactions hub.